UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004467 |
|---|---|
| Receipt number | R000005345 |
| Scientific Title | Evaluation of reproducibility for a biomarker as the prediction of prognosis after radiotherapy for the patients with cervical cancer |
| Date of disclosure of the study information | 2010/11/01 |
| Last modified on | 2023/06/14 16:47:35 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/10/27 20:58:52 | ||
| 2 | Update | 2012/10/25 15:47:56 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2012/10/25 16:49:47 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2012/10/25 16:53:14 | Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2012/10/25 16:53:45 | Target sample size |
|
| 6 | Update | 2013/04/30 14:35:03 | Recruitment status Date of protocol fixation Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2014/10/27 18:30:12 | Email Co-sponsor Co-sponsor |
|
| 8 | Update | 2014/10/27 18:34:49 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 9 | Update | 2019/11/06 17:04:52 | Study type Basic design Randomization Randomization unit Blinding Control Stratification Dynamic allocation Institution consideration Blocking Concealment No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 10 | Update | 2019/11/06 17:39:49 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Category of Funding Organization Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel |
|
| 11 | Update | 2023/05/31 17:51:02 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 12 | Update | 2023/06/14 16:44:09 | Date of IRB Other related information Other related information |
|
| 13 | Update | 2023/06/14 16:46:27 | Recruitment status |
|
| 14 | Update | 2023/06/14 16:47:35 | Publication of results |
